SHARE
Point Of Care Diagnostics Market

Point of Care Diagnostics Market Forecasts to 2028 – Global Analysis By Platform (Lateral Flow Assays, Molecular Diagnostics, Microfluidics, Immunoassays, Biosensors, Agglutination Assays, Solid Phase, Dipsticks ) and By Geography

5.0 (58 reviews)
Published: October 2021 ID: SMRC15488
5.0 (58 reviews)
Published: October 2021 ID: SMRC15488

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Point of Care Diagnostics Market is accounted for $29.50 billion in 2020 and is expected to reach $80.67 billion by 2028 growing at a CAGR of 13.4% during the forecast period. Factors such as growing adoption of home-based point of care devices, increasing prevalence of various chronic diseases, and technological advancements in the field of healthcare are driving the growth of the market. However, time-consuming regulatory policies are hampering the growth of the market.

Point of care diagnostics are the techniques used for early and quick diagnosis of diseases. These techniques are highly sensitive and cost-effective. The results of care are timely and offer rapid treatment to the patient.

Based on the product, the glucose monitoring segment is anticipated to expand at a rapid pace during the forecast period owing to the growing diabetic patient population and the increasing demand for home glucose testing. By geography, North America is going to have high growth during the forecast period which can be attributed to the rising healthcare expenditure and increasing awareness regarding the benefits of early disease diagnosis.

Some of the key players profiled in the Point of Care Diagnostics Market include Becton, Dickinson, and Company (BD), Abbott Laboratories, Johnson & Johnson, Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd.), Danaher Corporation, Sekisui Diagnostics, Siemens, Instrumentation Laboratory (A Werfen Company), Trinity Biotech, Accubiotech, PTS Diagnostics (A Part of Sinocare Inc.), Chembio Diagnostics, Nova Biomedical, EKF Diagnostics, and Quidel.

Prescription Modes Covered:
• Over the Counter Testing
• Prescription-Based Testing

Platforms Covered:
• Lateral Flow Assays (Immunochromatography Tests)
• Molecular Diagnostics
• Microfluidics
• Immunoassays
• Biosensors
• Agglutination Assays
• Solid Phase
• Dipsticks     

Products Covered:
• Tumor/Cancer Marker Testing
• Pregnancy and Fertility Testing
• Urinalysis Testing
• Cholesterol Testing
• Glucose Monitoring
• Hematology and Hemostasis Testing
• Drug and Alcohol Abuse Testing
• Fecal Occult Testing
• Infectious Disease Testing Products
• Cardiometabolic Testing
• Coagulation Monitoring Products 

Applications Covered:
• Observational Clinical Trials
• Interventional Clinical Trials

End Users Covered:
• Professional Diagnostic Centers
• Research Laboratories
• Assisted Living Healthcare Facilities 
• Home Care
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary    
      
2 Preface     

 2.1 Abstract    
 2.2 Stake Holders   
 2.3 Research Scope   
 2.4 Research Methodology  
  2.4.1 Data Mining  
  2.4.2 Data Analysis  
  2.4.3 Data Validation  
  2.4.4 Research Approach  
 2.5 Research Sources   
  2.5.1 Primary Research Sources 
  2.5.2 Secondary Research Sources 
  2.5.3 Assumptions  
      
3 Market Trend Analysis   
 3.1 Introduction   
 3.2 Drivers    
 3.3 Restraints    
 3.4 Opportunities   
 3.5 Threats    
 3.6 Product Analysis   
 3.7 Application Analysis   
 3.8 End User Analysis   
 3.9 Emerging Markets   
 3.10 Impact of Covid-19   
      
4 Porters Five Force Analysis   

 4.1 Bargaining power of suppliers  
 4.2 Bargaining power of buyers  
 4.3 Threat of substitutes   
 4.4 Threat of new entrants  
 4.5 Competitive rivalry   
      
5 Global Point of Care Diagnostics Market, By Prescription Mode
 5.1 Introduction   
 5.2 Over the Counter Testing   
 5.3 Prescription-Based Testing  
      
6 Global Point of Care Diagnostics Market, By Platform
 6.1 Introduction   
 6.2 Lateral Flow Assays (Immunochromatography Tests)
 6.3 Molecular Diagnostics  
 6.4 Microfluidics   
 6.5 Immunoassays   
 6.6 Biosensors   
 6.7 Agglutination Assays   
 6.8 Solid Phase   
 6.9 Dipsticks     
      
7 Global Point of Care Diagnostics Market, By Product 
 7.1 Introduction   
 7.2 Tumor/Cancer Marker Testing  
 7.3 Pregnancy and Fertility Testing  
 7.4 Urinalysis Testing   
 7.5 Cholesterol Testing   
 7.6 Glucose Monitoring   
  7.6.1 Lancets & Lancing Devices 
  7.6.2 Strips   
  7.6.3 Meters    
 7.7 Hematology and Hemostasis Testing 
 7.8 Drug and Alcohol Abuse Testing  
 7.9 Fecal Occult Testing   
 7.10 Infectious Disease Testing Products 
  7.10.1 Respiratory Infection Testing 
  7.10.2 Influenza Testing  
  7.10.3 Human Immunodeficiency Virus (HIV) Testing
  7.10.4 Healthcare-Associated Infection (HAI) Testing
  7.10.5 Sexually Transmitted Disease (STD) Testing
  7.10.6 Tropical Disease Testing 
  7.10.7 Hepatitis C Testing  
 7.11 Cardiometabolic Testing  
  7.11.1 HBA1C Testing     
  7.11.2 Blood Gas/Electrolytes Testing 
  7.11.3 Cardiac Marker Testing  
 7.12 Coagulation Monitoring Products 
  7.12.1 Activated Clotting Time (ACT/APTT) Testing
  7.12.2 Prothrombin Time (PT)/International Normalized Ratio (INR) Testing
      
8 Global Point of Care Diagnostics Market, By Application
 8.1 Introduction   
 8.2 Observational Clinical Trials  
 8.3 Interventional Clinical Trials  
      
9 Global Point of Care Diagnostics Market, By End User
 9.1 Introduction   
 9.2 Professional Diagnostic Centers  
  9.2.1 Hospitals/Critical Care Centers 
  9.2.2 Outpatient Healthcare & Ambulatory Care Settings
 9.3 Research Laboratories  
 9.4 Assisted Living Healthcare Facilities   
 9.5 Home Care   
 9.6 Other End Users   
  9.6.1 Medical Universities  
  9.6.2 Not-for-Profit Organizations    
      
10 Global Point of Care Diagnostics Market, By Geography
 10.1 Introduction   
 10.2 North America   
  10.2.1 US   
  10.2.2 Canada   
  10.2.3 Mexico   
 10.3 Europe    
  10.3.1 Germany   
  10.3.2 UK   
  10.3.3 Italy   
  10.3.4 France   
  10.3.5 Spain   
  10.3.6 Rest of Europe  
 10.4 Asia Pacific   
  10.4.1 Japan   
  10.4.2 China   
  10.4.3 India   
  10.4.4 Australia   
  10.4.5 New Zealand  
  10.4.6 South Korea  
  10.4.7 Rest of Asia Pacific  
 10.5 South America   
  10.5.1 Argentina   
  10.5.2 Brazil   
  10.5.3 Chile   
  10.5.4 Rest of South America 
 10.6 Middle East & Africa   
  10.6.1 Saudi Arabia  
  10.6.2 UAE   
  10.6.3 Qatar   
  10.6.4 South Africa  
  10.6.5 Rest of Middle East & Africa 
      
11 Key Developments    
 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
 11.2 Acquisitions & Mergers  
 11.3 New Product Launch   
 11.4 Expansions   
 11.5 Other Key Strategies   
      
12 Company Profiling    
 12.1 Becton, Dickinson, and Company (BD)   
 12.2 Abbott Laboratories       
 12.3 Johnson & Johnson   
 12.4 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd.)
 12.5 Danaher Corporation       
 12.6 Sekisui Diagnostics   
 12.7 Siemens     
 12.8 Instrumentation Laboratory (A Werfen Company)   
 12.9 Trinity Biotech    
 12.10 Accubiotech   
 12.11 PTS Diagnostics (A Part of Sinocare Inc.)  
 12.12 Chembio Diagnostics    
 12.13 Nova Biomedical    
 12.14 EKF Diagnostics      
 12.15 Quidel    


List of Tables     
1 Global Point of Care Diagnostics Market Outlook, By Region (2019-2028) ($MN)
2 Global Point of Care Diagnostics Market Outlook, By Prescription Mode (2019-2028) ($MN)
3 Global Point of Care Diagnostics Market Outlook, By Over the Counter Testing (2019-2028) ($MN)
4 Global Point of Care Diagnostics Market Outlook, By Prescription-Based Testing (2019-2028) ($MN)
5 Global Point of Care Diagnostics Market Outlook, By Platform (2019-2028) ($MN)
6 Global Point of Care Diagnostics Market Outlook, By Lateral Flow Assays (Immunochromatography Tests) (2019-2028) ($MN)
7 Global Point of Care Diagnostics Market Outlook, By Molecular Diagnostics (2019-2028) ($MN)
8 Global Point of Care Diagnostics Market Outlook, By Microfluidics (2019-2028) ($MN)
9 Global Point of Care Diagnostics Market Outlook, By Immunoassays (2019-2028) ($MN)
10 Global Point of Care Diagnostics Market Outlook, By Biosensors (2019-2028) ($MN)
11 Global Point of Care Diagnostics Market Outlook, By Agglutination Assays (2019-2028) ($MN)
12 Global Point of Care Diagnostics Market Outlook, By Solid Phase (2019-2028) ($MN)
13 Global Point of Care Diagnostics Market Outlook, By Dipsticks (2019-2028) ($MN)
14 Global Point of Care Diagnostics Market Outlook, By Product (2019-2028) ($MN)
15 Global Point of Care Diagnostics Market Outlook, By Tumor/Cancer Marker Testing (2019-2028) ($MN)
16 Global Point of Care Diagnostics Market Outlook, By Pregnancy and Fertility Testing (2019-2028) ($MN)
17 Global Point of Care Diagnostics Market Outlook, By Urinalysis Testing (2019-2028) ($MN)
18 Global Point of Care Diagnostics Market Outlook, By Cholesterol Testing (2019-2028) ($MN)
19 Global Point of Care Diagnostics Market Outlook, By Glucose Monitoring (2019-2028) ($MN)
20 Global Point of Care Diagnostics Market Outlook, By Lancets & Lancing Devices (2019-2028) ($MN)
21 Global Point of Care Diagnostics Market Outlook, By Strips (2019-2028) ($MN)
22 Global Point of Care Diagnostics Market Outlook, By Meters (2019-2028) ($MN)
23 Global Point of Care Diagnostics Market Outlook, By Hematology and Hemostasis Testing (2019-2028) ($MN)
24 Global Point of Care Diagnostics Market Outlook, By Drug and Alcohol Abuse Testing (2019-2028) ($MN)
25 Global Point of Care Diagnostics Market Outlook, By Fecal Occult Testing (2019-2028) ($MN)
26 Global Point of Care Diagnostics Market Outlook, By Infectious Disease Testing Products (2019-2028) ($MN)
27 Global Point of Care Diagnostics Market Outlook, By Respiratory Infection Testing (2019-2028) ($MN)
28 Global Point of Care Diagnostics Market Outlook, By Influenza Testing (2019-2028) ($MN)
29 Global Point of Care Diagnostics Market Outlook, By Human Immunodeficiency Virus (HIV) Testing (2019-2028) ($MN)
30 Global Point of Care Diagnostics Market Outlook, By Healthcare-Associated Infection (HAI) Testing (2019-2028) ($MN)
31 Global Point of Care Diagnostics Market Outlook, By Sexually Transmitted Disease (STD) Testing (2019-2028) ($MN)
32 Global Point of Care Diagnostics Market Outlook, By Tropical Disease Testing (2019-2028) ($MN)
33 Global Point of Care Diagnostics Market Outlook, By Hepatitis C Testing (2019-2028) ($MN)
34 Global Point of Care Diagnostics Market Outlook, By Cardiometabolic Testing (2019-2028) ($MN)
35 Global Point of Care Diagnostics Market Outlook, By HBA1C Testing (2019-2028) ($MN)
36 Global Point of Care Diagnostics Market Outlook, By Blood Gas/Electrolytes Testing (2019-2028) ($MN)
37 Global Point of Care Diagnostics Market Outlook, By Cardiac Marker Testing (2019-2028) ($MN)
38 Global Point of Care Diagnostics Market Outlook, By Coagulation Monitoring Products (2019-2028) ($MN)
39 Global Point of Care Diagnostics Market Outlook, By Activated Clotting Time (ACT/APTT) Testing (2019-2028) ($MN)
40 Global Point of Care Diagnostics Market Outlook, By Prothrombin Time (PT)/International Normalized Ratio (INR) Testing (2019-2028) ($MN)
41 Global Point of Care Diagnostics Market Outlook, By Application (2019-2028) ($MN)
42 Global Point of Care Diagnostics Market Outlook, By Observational Clinical Trials (2019-2028) ($MN)
43 Global Point of Care Diagnostics Market Outlook, By Interventional Clinical Trials (2019-2028) ($MN)
44 Global Point of Care Diagnostics Market Outlook, By End User (2019-2028) ($MN)
45 Global Point of Care Diagnostics Market Outlook, By Professional Diagnostic Centers (2019-2028) ($MN)
46 Global Point of Care Diagnostics Market Outlook, By Hospitals/Critical Care Centers (2019-2028) ($MN)
47 Global Point of Care Diagnostics Market Outlook, By Outpatient Healthcare & Ambulatory Care Settings (2019-2028) ($MN)
48 Global Point of Care Diagnostics Market Outlook, By Research Laboratories (2019-2028) ($MN)
49 Global Point of Care Diagnostics Market Outlook, By Assisted Living Healthcare Facilities (2019-2028) ($MN)
50 Global Point of Care Diagnostics Market Outlook, By Home Care (2019-2028) ($MN)
51 Global Point of Care Diagnostics Market Outlook, By Other End Users (2019-2028) ($MN)
52 Global Point of Care Diagnostics Market Outlook, By Medical Universities (2019-2028) ($MN)
53 Global Point of Care Diagnostics Market Outlook, By Not-for-Profit Organizations (2019-2028) ($MN)
      
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials